Cresilon

Series-A
cresilon.com Biotech & Healthcare
Total Funding $25M
Latest Round $25M Series-A
Last Announced Oct 27, 2022
Investors Undisclosed
Decision Makers 5 Verified

About Cresilon

Our plant-based technology stops traumatic and surgical bleeds in seconds without the need for manual pressure. Stop bleeding in seconds.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website cresilon.com
Domain Registered Date Jul 6, 2016

Social & Network Presence

X / Twitter Profile @Cresilon (1.1K followers) Created on Jan 2011
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $25,000,000 · Series-A

    startupintros.com

  2. Milestone

    Website domain registered

    cresilon.com

  3. Milestone

    X account created (@Cresilon)

    1.1K followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Cresilon.

Funding History

1 Round
Series-A · Oct 27, 2022

Founders & Leadership

1

Joe Landolina

Co-Founder and CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts